Arena Pharmaceuticals, Inc. (ARNA): You Need To See These 5 Points
A sharp drop in Arena Pharmaceuticals (NASDAQ:ARNA) followed after the company reported quarterly earnings and a withdrawal of its Marketing Authorization Application (“MAA”) ...
Posts Tagged ‘NASDAQ:VVUS’
VIVUS, Inc. (VVUS): Is It Really Time To Sell?
Biotech company VIVUS, Inc. (NASDAQ:VVUS) has struggled to pick up sales of its obesity medication Qsymia since the drug was launched in September.
VIVUS, Inc. (VVUS): You’ve Got To Spend Money To Make Money
VIVUS, Inc. (NASDAQ:VVUS) has the first part down.
Pfizer Inc. (PFE), Johnson & Johnson (JNJ): The Next Frontier?
Only 19 drugs have ever netted at least $5 billion in annual sales -- and most were at their peak --according to a list compiled by Simon King of Forbes earlier this year.
UnitedHealth Group Inc. (UNH), Alcoa Inc (AA), VIVUS, Inc. (VVUS): Who Sent The Dow (.DJI) Up?
In every bull market, there comes a time when nothing can seem to stop stocks from rising.
Arena Pharmaceuticals, Inc. (ARNA): This Could Be A Major Blockbuster
It's been a long road, but Eisai and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)' obesity drug Belviq can finally launch in 30 days.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) & Orexigen Therapeutics, Inc. (OREX): The Bottom Line
VIVUS, Inc. (NASDAQ:VVUS)' Qsymia has not received the unconditional consumer love that investors were hoping.
Arena Pharmaceuticals, Inc. (ARNA): U.S. Approved Obesity Drug Derailed in EU
Most, and probably all, of that decline is because of the European decision, or lack thereof. Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (ARNA): Here’s What You Missed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS), Orexigen Therapeutics, Inc. (OREX): Have Drugmakers Found the Panacea for Obesity? (Part I)
After a gap of several years, there seems to be a candidate in the obesity drug market that could turn out to be a long-term winner.
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)’s Update, New VIVUS, Inc. (VVUS) Deal & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Johnson & Johnson (NYSE:JNJ), Orexigen Therapeutics, Inc.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS) & The Panacea For Obesity?
In the previous part of this article, I discussed the potential obesity market and some promising drugs on the scene.
Apple Inc. (AAPL): How This Tech Giant Accidentally Revolutionized Health Care
Apple Inc. (NASDAQ:AAPL) didn't necessarily intend to revolutionize health care, but that's exactly what happened.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) & Some Key Catalysts Approaching
The obesity stocks are perhaps some of the most discussed and followed stocks in the entire biotechnology sector.
Trending News: Exxon Mobil Corporation (XOM), Arena Pharmaceuticals, Inc. (ARNA), QUALCOMM, Inc. (QCOM)
Editor's Note: Related tickers: Exxon Mobil Corporation (NYSE:XOM), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), 3M Co (NYSE:MMM), Akamai Technologies, Inc.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Anti-Obesity Stocks Are Attractively Priced
The obesity market was one of the most attractive sectors a year ago, and the shares of companies developing anti-obesity drugs were the pharmaceutical sector's hottest properties...
Herbalife Ltd. (HLF), Arena Pharmaceuticals, Inc. (ARNA), Vivus, Inc. (VVUS): Stocks to Know for the Obesity Epidemic
Obesity rates have been steadily growing in the developed world, in particular in the US, which has the world’s highest rate of obesity.
Trending News: Apple Inc (AAPL) and Bank Of America Corp (BAC) Dropping Like Rocks, Here’s Why
Editor's Note: Related tickers: Apple Inc. (NASDAQ:AAPL), Facebook Inc (NASDAQ:FB), Bank of America Corp (NYSE:BAC), Yahoo! Inc. (NASDAQ:YHOO), Cirrus Logic, Inc.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): The US’s Hidden Obesity Epidemic
The United States is the fattest country in the world -- and I'm not talking about our wallets, folks! According to the Centers for Disease Control and Prevention, a disheartening...
Biopharma News: Theravance Inc (THRX), VIVUS, Inc. (VVUS), Amgen, Inc. (AMGN)
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc.
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds' portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge fund interest of late.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA), and How Doctors Actually Diagnose Obesity
The obesity crisis in America is a hotly debated topic. According to the Centers for Disease Control and Prevention, more than 35% of adults in the U.S.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Ten Flabbergasting Costs of America’s Obesity Epidemic
Obesity is costing us big time. Three times more Americans are obese now than were in 1960. Six times more Americans are now extremely obese than a half-century ago.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Which Obesity Drug Will Boost Your Portfolio?
In 2012, the FDA approved two obesity drugs for use in the United States. One drug, named "Belviq", is from Arena Pharmaceuticals, Inc.
Do Hedge Funds and Insiders Love VIVUS, Inc. (NASDAQ:VVUS)?
Is VIVUS, Inc. (NASDAQ:VVUS) a buy right now? Investors who are in the know are taking a bearish view.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA), Orexigen Therapeutics, Inc. (OREX): The Big Weight-Drug Wait
"Wait" seems to be the operative word for the obesity drug industry these days. Investors in VIVUS, Inc.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Is Obesity Really a Dangerous Disease?
Obesity drugmakers Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , VIVUS, Inc. (NASDAQ:VVUS) , and Orexigen Therapeutics, Inc.
5 Hidden Causes of Obesity: Arena Pharmaceuticals, Inc. (ARNA), VIVUS Inc. (VVUS)
Obesity-drug makers Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS Inc. (NASDAQ:VVUS), and Orexigen Therapeutics, Inc.
Arena Pharmaceuticals, Inc. (ARNA) Faces Europe’s Obesity Opportunity: VIVUS Inc. (VVUS)
You can't find a hotter topic in health care than obesity.
Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY): 3 Big Concerns for the Pharmaceutical Industry
It's not uncommon for me to applaud the pharmaceutical industry as a solid long-term investment.
Cancer Prevention and the Hidden Risk of Obesity: VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)
Obesity has become one of the most prevalent diseases in the United States.
This Investment Just Became More Attractive: VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)
The FDA approval of obesity drugs has been received with a lot of investor enthusiasm. The FDA has thus far approved two drugs: Qsymia from VIVUS, Inc.
Tick Tock Goes the Obesity Clock: Orexigen Therapeutics, Inc. (OREX), VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)
The Food and Drug Administration made the company run a clinical trial to confirm that there weren't any heart-related complications with Contrave.
Better Health, an iPhone App Away: Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ)
An Apple a day might not keep the doctor away, but the company's AppStore carries several solutions for tracking health care on the go -- and pharmaceutical companies continue...
What’s Behind MannKind Corporation (MNKD)’s Incredible Run? – Pfizer Inc. (PFE)
After seeing MannKind Corporation (NASDAQ:MNKD) rocket upwards over the last week, Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to ...
Questcor Pharmaceuticals Inc (QCOR) Will Carry On its Rise: VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)
Some companies were happy to see the end of 2012. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) was one of them.
Is the Wait Over? – Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS), Orexigen Therapeutics, Inc. (OREX)
The obesity industry is new on the stock block, but it has already become one of the most followed industries in our market.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Is There a “First-Mover” Advantage in Biotech?
The early bird gets the worm. Business gurus might not use that old phrase, but many of them tout the principle behind it.
This Week in Biotech: Dynavax Technologies Corporation (DVAX), Zogenix, Inc. (ZGNX)
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
3 Humongous Health-Care Stocks Last Week: Orexigen Therapeutics, Inc. (OREX), Optimer Pharmaceuticals, Inc. (OPTR)
While the overall market seemed to be deciding this week whether to keep the rally going or take a break, several stocks in the world of health care left no doubt.
3 Horrendous Health-Care Stocks This Week: VIVUS, Inc. (VVUS), Accretive Health, Inc. (AH), Dynavax Technologies Corporation (DVAX)
While the federal government now gets to deal with "massive" budget cuts of around 2.3% of total annual federal spending put into law by President Obama and Congress, some investors...
3 Bio-Pharmaceuticals You Can’t Ignore: Arena Pharmaceuticals, Inc. (ARNA), VIVUS Inc. (VVUS)
The last year has been a stellar one for the biotechnology industry.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals Inc. (ARNA): Just 12,500% More Growth for an Obesity Blockbuster
Of course, that's kind of like talking about an huge gnat. I'm sure they probably exist, but you're working from such a small base, that the added size doesn't amount to much.
VIVUS, Inc. (VVUS) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
This Week in Biotech: VIVUS, Inc. (VVUS), Roche Holdings Ltd-Spons Adr (RHHBY)
With the SPDR S&P Biotech Index up 25% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Hot Off the Press: VIVUS, Inc. (VVUS)’s Appeal for EU Approval Denied
Days after launching its obesity drug Qsymia in the U.S. last September, VIVUS, Inc.
What Is It With Arena Pharmaceuticals, Inc. (ARNA) and the EMA?
Regardless of FDA approval, safety issues have been a great concern with regulators and medical practitioners when it comes to obesity drugs.
The FDA Made Biotech Investing Harder (But More Lucrative): Johnson & Johnson (JNJ)
For instance, it's hard to make money on shoo-in Food and Drug Administration approvals. The approval is already reflected in the price.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Will There Ever Be an Obesity Drug Blockbuster?
Investors are anxiously waiting for the launch of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai's obesity drug Belviq, which will match up with VIVUS, Inc.
